Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07207369) titled 'A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars' on Oct. 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).

Primary Sponsor: AbbVie

Condition: Acne Scars

Intervention: Device: ELAPR002f Injectable Gel

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: October 16, 2025

Target Sample Size: 395

To know more, visit https://clinicaltrials.gov/study/NCT07207369

P...